Applications are invited for a Senior Research Associate in Bioinformatics to undertake translational cancer research to aid prostate cancer patients. The studies are at the exciting validation stage critical to bring two molecular tests to fruition and use in the clinic.
Our aim is to improve prostate cancer diagnosis and prognosis and to this end we have developed two predictors: The PUR test, and DESNT. As Senior Research Associate, you will propel PUR and DESNT towards clinically implementable tests for the diagnosis and prognosis of prostate cancer to improve patient’s care. This is a key role partly funded by a Prostate Cancer UK and Movember Foundation Research Innovation Award. You will be involved in all aspects of the collection, data management, development of analysis pipelines, and analysis of patient’s data and expression data in this project including the commercialisation of these tests.
The research will be based at the Diagnostics lab in the Cancer Genetics team at the Norwich Medical School, which is an interdisciplinary team comprising a mixture of bioinformaticians and lab-based scientists. We have a broad interest in translational cancer based molecular studies with the aim of improving patient care. The appointee will link into other studies within Cancer Genetics and with collaborating teams and hospitals both inside and outside the UK.
You will have a PhD degree or equivalent experience in computer science or a relevant numeric biological subject, (e.g. bioinformatics, computational biology), strong organisational skills and a good track record in publications. Experience in performing machine learning techniques and of managing a project with large amounts of data is also essential together with an enthusiasm for working in an interdisciplinary environment and the ability to interact and communicate effectively with scientists from other disciplines including clinicians, scientific computing IT, and biologists.
Significant postdoctoral experience and experience in clinical statistics, data management, and cancer research is also advantageous.
Seeking to promote an equitable representation of men and women among its staff, the School encourages applications from women and those from minority ethnic groups. Appointment will be made on merit.
This full-time post is offered on a fixed term basis from 1 July 2021 for 2 years. Salary: £33,797 to £40,322 per annum Closing date: 21st January 2021
For more information on this project: http://bit.ly/UEA_bioinf2